Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pharma-Bio Serv (PBSV) Loans and Notes Receivables (2018 - 2020)

Pharma-Bio Serv's Loans and Notes Receivables history spans 3 years, with the latest figure at $1.2 million for Q4 2020.

  • For Q4 2020, Loans and Notes Receivables changed 0.0% year-over-year to $1.2 million; the TTM value through Oct 2020 reached $1.2 million, changed 0.0%, while the annual FY2020 figure was $1.2 million, 0.0% changed from the prior year.
  • Loans and Notes Receivables reached $1.2 million in Q4 2020 per PBSV's latest filing, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $1.8 million in Q4 2018 to a low of $1.2 million in Q4 2019.
  • Average Loans and Notes Receivables over 3 years is $1.4 million, with a median of $1.2 million recorded in 2019.
  • Peak YoY movement for Loans and Notes Receivables: decreased 28.57% in 2019, then changed 0.0% in 2020.
  • A 3-year view of Loans and Notes Receivables shows it stood at $1.8 million in 2018, then fell by 28.57% to $1.2 million in 2019, then changed by 0.0% to $1.2 million in 2020.
  • Per Business Quant, the three most recent readings for PBSV's Loans and Notes Receivables are $1.2 million (Q4 2020), $1.2 million (Q4 2019), and $1.8 million (Q4 2018).